Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

HOME
Pharma Business
About us
- Media Kit
- Privacy Policy
Contact

Search for:

Tag: Cipla

Cipla launching low-dose Efavirenz 400 mg HIV infection therapy

November 30, 2015 Off

Cipla launching low-dose Efavirenz 400 mg HIV infection therapy

By Dino Mustafić

Cipla launching low-dose Efavirenz 400 mg HIV infection therapy

Popular posts

Medicago, GSK report primary and secondary endpoints with available data met in trial dominated by COVID-19 variants

December 10, 2021 Off

Ring Therapeutics Announces New Strategic Partnerships with A*STAR and SERI to Establish Gene Therapy R&D Efforts in Singapore, a Growing Global Biotech Hub

November 5, 2024 Off

Cosentyx meets the primary endpoints

June 15, 2015 Off

Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

June 15, 2015 Off

Strensiq in HPP patiens therapy get approval from European Commission

September 13, 2015 Off

Proudly powered by WordPress | Theme: Envo Magazine